Skip to content

Why Subscribe
About Us
Accreditation
Library
Live Events
Sign Up / Login

Why Subscribe
About Us
Accreditation
Library
Live Events
Sign Up / Login

Library

By pinki shah / May 14, 2022

Speciality

Author / Speaker

Title of Presentation

Type of Media

Event

2024 Event

Clear

Displaying 876 - 900 of 2,573

«
1
…
34
35
36
37
38
…
103
»

Targeted Therapy for B- and T-cell Non-Hodgkins Lymphomas

Targeted Therapy for B- and T-cell Non-Hodgkins Lymphomas

By: Eduardo M. Sotomayor, MD

Changing the landscape of treatment in Peripheral T-cell Lymphoma

Changing the landscape of treatment in Peripheral T-cell Lymphoma

By: Luis E. Fayad, MD

Updates in Multiple Myelom

Updates in Multiple Myelom

By: Aaron S. Rosenberg, MD, MS

Updates in CML and CLL

Updates in CML and CLL

By: Alexis M. Cruz Chacon, MD

Immunotherapy in Heme Malignancies

Immunotherapy in Heme Malignancies

By: Arta M. Monjazeb, MD, PhD

New Therapeutic Options in the Myelodysplastic Syndromes

New Therapeutic Options in the Myelodysplastic Syndromes

By: Brian A. Jonas, MD, PhD, FACP

Cancer And Thrombosis

Cancer And Thrombosis

By: Craig S. Kitchens,, MD, MACP

DOACs in Cancer

DOACs in Cancer

By: Craig S. Kitchens,, MD, MACP

B-Cell NHL and Hodgkin’s Disease Biologicals, Checkpoint Inhibitors, CAR-T cells

B-Cell NHL and Hodgkin’s Disease Biologicals, Checkpoint Inhibitors, CAR-T cells

By: Eduardo M. Sotomayor, MD

B-Cell NHL and Hodgkin’s Disease

B-Cell NHL and Hodgkin’s Disease

By: Eduardo M. Sotomayor, MD

CLL & CML (a lot on the first and not much on the second) Part 2

CLL & CML (a lot on the first and not much on the second) Part 2

By: Javier Pinilla-Ibarz, MD, PhD

CLL & CML (a lot on the first and not much on the second) Part 1

CLL & CML (a lot on the first and not much on the second) Part 1

By: Javier Pinilla-Ibarz, MD, PhD

What New in Hematopoietic Stem Cell Transplantation

What New in Hematopoietic Stem Cell Transplantation

By: Joseph M. Tuscano, MD

Acute Myeloid and Lymphoid Leukemias

Acute Myeloid and Lymphoid Leukemias

By: Kevin Kelly, MD, PhD

Diffuse Large Cell Lymphoma - The Latest and Greatest

Diffuse Large Cell Lymphoma - The Latest and Greatest

By: Leslie Popplewell, MD, FACP

How to Decide which Frontline Therapy in MM After First Relapse Post-Transplant

How to Decide which Frontline Therapy in MM After First Relapse Post-Transplant

By: Melissa Alsina, MD

By: Mohamed A. Kharfan-Dabaja, MD, MBA

Chimeric Antigen Receptor (CAR) T Cell Therapy - Progress and Challenges

Chimeric Antigen Receptor (CAR) T Cell Therapy - Progress and Challenges

By: Mohamed A. Kharfan-Dabaja, MD, MBA, FACP

Management of Metastatic Breast Cancer

Management of Metastatic Breast Cancer

By: Noridza Rivera-Rodriguez, MD

Myelodysplasia and Secondary AML

Myelodysplasia and Secondary AML

By: Rami Komrokji, MD

Melanoma: Beyond Checkpoint Inhibitors

Melanoma: Beyond Checkpoint Inhibitors

By: Sanjiv S. Agarwala, MD

Multiple Myeloma Transplant and Non-transplant Modalities

Multiple Myeloma Transplant and Non-transplant Modalities

By: Sikander Ailawadhi, MD

Lymphoma: State of the Art

Lymphoma: State of the Art

By: Alexey Danilov, MD, PhD

Clinical Update: Malignant Hematology

Clinical Update: Malignant Hematology

By: Atis Barzdins, MD

DLBCL & Hodgkin’s Disease: Novel Approaches

DLBCL & Hodgkin’s Disease: Novel Approaches

By: Eduardo Sotomayor, MD

«
1
…
34
35
36
37
38
…
103
»

Post navigation

← Previous View

© 2024 MEC Inc. All rights reserved | Digital Marketing by Katapult Marketing

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok